General discussion, page-168

where did the $2M figure come from? gut feeling. last quarter they said they projected $1.45M cash burn this quarter and they have signed a lot more deals which cost money for new products, paid for patents and FDA consulting advice etc, and have to pay the medical board.

IMO, they will miss the dead line for Suds 4 cent options. not because they didn't try, but because there's so much to do with patent applications and other regulatory work. I think they will announce an amended incentive structure for Suds options that share holders will have to vote on cause it's not fair to miss out on some cheap oppies for just slightly missing deadlines and they aren't doing the AXIM product anymore.